Program in Peritoneal Surface Malignancy, Washington Cancer Institute, Washington, DC, USA.
Department of Pathology, MedStar Washington Hospital Center, Washington, DC, USA.
Eur J Surg Oncol. 2024 Jul;50(7):108373. doi: 10.1016/j.ejso.2024.108373. Epub 2024 May 1.
For peritoneal metastases from a primary appendiceal mucinous neoplasm to exist, the thin wall of the appendix must perforate to allow mucus or mucus plus tumor cells to gain access to the peritoneal spaces. The proportion of specimens containing tumor cells within mucus as compared to mucus only outside the appendix may have prognostic significance. The histopathology of tumor masses was determined from the specimens resected at the cytoreductive surgery (CRS). The presence versus absence of tumor cells in mucus and the proportion of specimens with tumor cells was determined and correlated with the overall survival of these patients. In 418 patients with a complete cytoreduction for a low-grade appendiceal mucinous neoplasm (LAMN), the cellularity of all resected specimens was determined. The hazard ratio of overall survival of patients whose specimens had no cells as compared to specimens with cells in mucus by histology was 4.41 (1.61, 12.1) (p = 0.0039). If overall survival of patients with all specimens without tumor cells was compared to patients with specimens with 1-99 % tumor and compared to patients with 100 % of specimens with tumor cells, the hazard ratios were 4.3 (1.34, 13.8) (p = 0.0143) and 9.62 (2.93, 31.6) (p = 0.0002), respectively. The cellularity of mucus within the specimens removed by a complete CRS has strong prognostic implications in LAMN patients. LAMN with acellular specimens (LAMNa) as compared to LAMN with tumor cells in specimens (LAMNb) should be staged as different histologic subtypes of mucinous appendiceal neoplasms.
为了存在阑尾原发性粘液性肿瘤的腹膜转移,阑尾的薄壁必须穿孔,以便粘液或粘液加肿瘤细胞能够进入腹膜腔。与阑尾外仅含粘液的标本相比,在粘液中含有肿瘤细胞的标本比例可能具有预后意义。肿瘤肿块的组织病理学是从细胞减灭性手术(CRS)切除的标本中确定的。确定粘液中是否存在肿瘤细胞以及存在肿瘤细胞的标本比例,并将其与这些患者的总生存率相关联。在 418 例低级别阑尾粘液性肿瘤(LAMN)完全细胞减灭的患者中,确定了所有切除标本的细胞密度。与组织学上粘液中无细胞的标本相比,细胞密度无细胞的标本的总体生存率的危险比为 4.41(1.61,12.1)(p=0.0039)。如果将所有无肿瘤细胞的标本的患者的总生存率与有 1-99%肿瘤细胞的标本的患者以及有 100%肿瘤细胞的标本的患者进行比较,危险比分别为 4.3(1.34,13.8)(p=0.0143)和 9.62(2.93,31.6)(p=0.0002)。通过完全 CRS 切除的标本中粘液的细胞密度对 LAMN 患者具有强烈的预后意义。与标本中有肿瘤细胞的 LAMN(LAMNb)相比,无细胞标本的 LAMN(LAMNa)应作为不同的组织学亚型的粘液性阑尾肿瘤进行分期。
Eur J Surg Oncol. 2024-7
Eur J Surg Oncol. 2023-5
Ann Surg Oncol. 2018-11-12
Am J Surg Pathol. 2003-8
J Surg Oncol. 2024-11